Suppr超能文献

在大鼠静脉注射氯化镉和镉饱和金属硫蛋白-II后,进行用于评估镉的肾小球滤过率的清除率研究。

Clearance study for the estimation of glomerular filtration of Cd following the intravenous bolus of CdCl2 and Cd-saturated metallothionein-II in rats.

作者信息

Hayashi T, Terui J, Sudo J

机构信息

Department of Toxicology and Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Higashi-Nippon-Gakuen University, Hokkaido, Japan.

出版信息

Biol Pharm Bull. 1994 Apr;17(4):557-8. doi: 10.1248/bpb.17.557.

Abstract

A clearance study of Cd was carried out in rats that had received an intravenous bolus of CdCl2 or Cd-saturated metallothionein-II (Cd-MT-II) at 0.3 mg Cd/kg body weight. Urinary concentrations of Cd, and those corrected by the urine-plasma inulin ratio, were higher, by 2 or 3 orders of magnitude, for Cd-MT-II than for CdCl2. Fractional clearance of Cd was 0.0006 to 0.0029 for CdCl2, and 0.130 to 0.487 for Cd-MT-II. These findings denoted that the glomerular filtration of Cd was greater in the Cd-MT-II administration than in CdCl2 administration. This difference in the glomerular filtration of Cd gave a clear explanation for the greater nephrotoxic potential of Cd-MT-II. Also, our data revealed that when Cd was administered as Cd-MT-II, the concentration of Cd was 20 to 70 times higher at the end-point of the renal tubules than at its starting-point. This and the histopathological reports so far strongly suggest that the distally located tubules are highly resistant to intraluminal Cd.

摘要

对体重为0.3mg镉/千克的大鼠进行了镉清除研究,这些大鼠通过静脉推注接受了氯化镉或镉饱和的金属硫蛋白-II(Cd-MT-II)。尿液中镉的浓度以及通过尿-血浆菊粉比率校正后的浓度,Cd-MT-II比氯化镉高2到3个数量级。氯化镉的镉分数清除率为0.0006至0.0029,Cd-MT-II为0.130至0.487。这些发现表明,Cd-MT-II给药组中镉的肾小球滤过率高于氯化镉给药组。镉肾小球滤过的这种差异清楚地解释了Cd-MT-II更大的肾毒性潜力。此外,我们的数据显示,当以Cd-MT-II形式给予镉时,肾小管末端的镉浓度比其起始点高20至70倍。这一点以及迄今为止的组织病理学报告强烈表明,位于远端的肾小管对管腔内的镉具有高度抗性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验